Pavlakis N - Search Results

1

Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations.

Davis AP, Cooper WA, Boyer M, Lee JH, Pavlakis N, Kao SC. Davis AP, et al. Among authors: pavlakis n. Immunotherapy. 2021 Aug;13(11):941-952. doi: 10.2217/imt-2021-0090. Epub 2021 Jun 11. Immunotherapy. 2021. PMID: 34114474 Review.

2

Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.

Zhao L, Lee BY, Brown DA, Molloy MP, Marx GM, Pavlakis N, Boyer MJ, Stockler MR, Kaplan W, Breit SN, Sutherland RL, Henshall SM, Horvath LG. Zhao L, et al. Among authors: pavlakis n. Cancer Res. 2009 Oct 1;69(19):7696-703. doi: 10.1158/0008-5472.CAN-08-4901. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773444

3

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ. Kao SC, et al. Among authors: pavlakis n. Clin Cancer Res. 2010 Dec 1;16(23):5805-13. doi: 10.1158/1078-0432.CCR-10-2245. Epub 2010 Oct 18. Clin Cancer Res. 2010. PMID: 20956618

4

The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

Kao SC, Harvie R, Paturi F, Taylor R, Davey R, Abraham R, Clarke S, Marx G, Cullen M, Kerestes Z, Pavlakis N. Kao SC, et al. Among authors: pavlakis n. Lung Cancer. 2012 Feb;75(2):248-54. doi: 10.1016/j.lungcan.2011.06.007. Epub 2011 Jul 16. Lung Cancer. 2012. PMID: 21757252

5

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S. Kao SC, et al. Among authors: pavlakis n. Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1. Clin Lung Cancer. 2013. PMID: 22658812

6

Efficacy of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): analysis of the Australian subpopulation of the TRUST study.

Boyer M, Horwood K, Pavlakis N, De Souza P, Millward M, Stein B, Johnston M, Abell F, Rischin D. Boyer M, et al. Among authors: pavlakis n. Asia Pac J Clin Oncol. 2012 Sep;8(3):248-54. doi: 10.1111/j.1743-7563.2012.01540.x. Epub 2012 May 15. Asia Pac J Clin Oncol. 2012. PMID: 22898114 Clinical Trial.

7

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma.

Kao SC, Vardy J, Harvie R, Chatfield M, van Zandwijk N, Clarke S, Pavlakis N. Kao SC, et al. Among authors: pavlakis n. Support Care Cancer. 2013 Mar;21(3):697-705. doi: 10.1007/s00520-012-1569-6. Epub 2012 Aug 31. Support Care Cancer. 2013. PMID: 22936495 Clinical Trial.

8

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.

Nowak AK, Brown C, Millward MJ, Creaney J, Byrne MJ, Hughes B, Kremmidiotis G, Bibby DC, Leske AF, Mitchell PLR, Pavlakis N, Boyer M, Stockler MR. Nowak AK, et al. Among authors: pavlakis n. Lung Cancer. 2013 Sep;81(3):422-427. doi: 10.1016/j.lungcan.2013.05.006. Epub 2013 Jun 17. Lung Cancer. 2013. PMID: 23787063 Clinical Trial.

9

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA; START trial team. Butts C, et al. Lancet Oncol. 2014 Jan;15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9. Lancet Oncol. 2014. PMID: 24331154 Free article. Clinical Trial.

10

National Working Group Meeting on ALK diagnostics in lung cancer.

Cooper W, Fox S, O'Toole S, Morey A, Frances G, Pavlakis N, O'Byrne K, Dettrick A, Leong T, Rathi V, Spagnolo D, Hemmings C, Singh M, Moffat D, Tsao MS, Wilner K, Buller R, Pitman Lowenthal S, Arifeen S, Binko J, Alam M. Cooper W, et al. Among authors: pavlakis n. Asia Pac J Clin Oncol. 2014 Apr;10 Suppl 2:11-7. doi: 10.1111/ajco.12190. Asia Pac J Clin Oncol. 2014. PMID: 24673736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page